Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

15.64
+0.35002.29%
Volume:1.32M
Turnover:20.56M
Market Cap:1.54B
PE:-2.68
High:15.73
Open:15.33
Low:15.23
Close:15.29
52wk High:39.89
52wk Low:12.73
Shares:98.32M
Float Shares:80.72M
Volume Ratio:0.46
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-5.28
PE(LYR):-2.68

Loading ...

Ultragenyx grants 17,567 RSUs to 11 new hires under inducement plan

Reuters
·
May 23

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 23

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 23

Ultragenyx Pharma Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
May 21

Ultragenyx price target raised to $96 from $84 at Cantor Fitzgerald

TIPRANKS
·
May 21

Ultragenyx director Shehnaaz Suliman disposes 5,740 common shares for $144,228.8

Reuters
·
May 19

Ultragenyx shareholders approve amended 2023 incentive plan at annual meeting

Reuters
·
May 19

Ultragenyx price target lowered to $33 from $34 at Evercore ISI

TIPRANKS
·
May 12

Analysts Offer Insights on Healthcare Companies: Kodiak Sciences (KOD), IN8bio (INAB) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
May 11

Ultragenyx Pharmaceutical (RARE) Valuation Check After Recent Share Price Momentum And Long Term Pressure

Simply Wall St.
·
May 11

Ultragenyx Pharma Is Maintained at Buy by Guggenheim

Dow Jones
·
May 08

Ultragenyx price target lowered to $43 from $52 at Guggenheim

TIPRANKS
·
May 08

Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference

GlobeNewswire
·
May 07

Stock Track | Ultragenyx Pharmaceutical Soars 5.32% Intraday on Positive Analyst Ratings

Stock Track
·
May 06

Ultragenyx Pharma Is Maintained at Neutral by Wedbush

Dow Jones
·
May 06

Wedbush Trims Price Target on Ultragenyx Pharmaceutical to $26 From $27, Maintains Neutral Rating

MT Newswires Live
·
May 06

Ultragenyx Pharmaceutical (RARE) Receives a Buy from Wells Fargo

TIPRANKS
·
May 06

Barclays Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
May 06

Ultragenyx Pharmaceutical Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

REFILE-Ultragenyx Q1 revenue drop steeper than estimated; backs FY view

Reuters
·
May 06